cfMSC Therapy for Diabetes

Clinical trial NCT07495956 · RECRUITING

Trial details

NCT number: NCT07495956
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2026-03-16
Primary completion: 2029-03-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.